Premium
microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma
Author(s) -
Zhao Yiqiang,
Schetter Aaron J.,
Yang Geoffrey B.,
Nguyen Giang,
Mathé Ewy A.,
Li Peng,
Cai Hong,
Yu Lei,
Liu Fangfang,
Hang Dong,
Yang Haijun,
Wang Xin Wei,
Ke Yang,
Harris Curtis C.
Publication year - 2012
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.27954
Subject(s) - microrna , medicine , oncology , proportional hazards model , cohort , ctgf , gene expression , cancer research , gene , biology , growth factor , genetics , receptor
MicroRNAs (miRNAs) and inflammatory genes have a role in the initiation and development of esophageal squamous cell carcinoma (ESCC). In our study, we examined the potential of using miRNA and inflammatory gene expression patterns as prognostic classifiers for ESCC. Five miRNAs and 25 inflammatory‐related genes were measured by quantitative reverse transcriptase PCR in tumor tissues and adjacent noncancerous tissues from 178 Chinese patients with ESCC. The expression levels of miR‐21 ( p = 0.027), miR‐181b ( p = 0.002) and miR‐146b ( p = 0.021) in tumor tissue and miR‐21 ( p = 0.003) in noncancerous tissue were associated with overall survival of patients. These data were combined to generate a miRNA risk score that was significantly associated with worse prognosis ( p = 0.0001), suggesting that these miRNAs may be useful prognostic classifiers for ESCC. To construct an inflammatory gene prognostic classifier, we divided the population into training ( n = 124) and test cohorts ( n = 54). The expression levels of CRY61 , CTGF and IL‐18 in tumor tissue and VEGF in adjacent noncancerous tissue were modestly associated with prognosis in the training cohort | Z ‐score| > 1.5 and were subsequently used to construct a Cox regression‐based inflammatory risk score (IRS). IRS was significantly associated with survival in both the training cohort ( p = 0.002) and the test cohort ( p = 0.005). Furthermore, Cox regression models combining both miRNA risk score and IRS performed significantly better than models with either alone ( p < 0.001 likelihood ratio test). Therefore, miRNA and inflammatory gene expression patterns, alone or in combination, have potential as prognostic classifiers for ESCC and may help to guide therapeutic decisions.